查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092230

植體周圍炎市場——2026-2032年全球市場預測

Peri-implantitis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，植入周圍炎市場將成長至 19 億美元，複合年成長率為 6.50%。

主要市場統計數據
基準年 2025 12.2億美元
預計年份：2026年 13億美元
預測年份 2032 19億美元
複合年成長率 (%) 6.50%

植體周圍植入的執行摘要

植體周圍植入是一種與生物膜相關的發炎性疾病，會影響牙科植體周圍的組織。其特徵是植入周圍黏膜發炎和支持骨骼的進行性喪失。隨著全球牙科植體治療的普及，植體周圍植入的管理已成為牙醫、牙周病專家、口腔外科醫生、植入製造商、學術研究人員和醫療保險機構的首要任務。此疾病與斑塊堆積、牙周病史、吸菸、糖尿病、維護不當、黏接劑用量過多、義齒設計缺陷、患者特異性免疫反應密切相關。目前的臨床重點是早期診斷、基於風險的預防、非手術清創、再生和切除性手術方法、植入表面消毒以及長期的植入維護。目前，植體植入炎的治療現狀越來越受到循證方案、標準化病例定義、提高診斷準確性以及在維持植入功能的同時降低復發率的治療方法的需求所影響。對於醫療保健領域的所有相關人員而言，將預防、數位監測、微創治療以及提高患者依從性的策略融入植入護理的常規流程中，代表著未來的機會。

植入現狀的變革性變化

植入周圍炎的現狀正在經歷一場變革，這主要得益於臨床共識的不斷改進、數位化牙科的引入以及對預防的日益重視。先前，由於臨床研究中疾病定義、嚴重程度分級和療效指標的不一致，治療方法多種多樣。如今，採用更標準化的診斷框架提高了研究結果的可比性，並有助於臨床決策，尤其是在探診出血、探診深度變化、化膿、 觀察的骨吸收以及基準植入記錄等方面。同時，牙科診療正從臨時介入轉向系統性的植入維護方案，其中包括風險評估、專業的生物膜控制、咬合評估和病患教育。治療方法的創新也正在重塑醫療服務的提供方式。為了改善臨床療效，目前正在評估噴砂消毒、雷射輔助治療、超音波和鈦合金相容器械、抗感染輔助劑、局部抗菌劑、再生生醫材料以及引導骨再生（GBR）技術。然而，已發表的證據持續表明，沒有單一的治療方法能夠普遍有效，這凸顯了病例選擇、牙齒缺損形態、植入表面特徵以及醫師經驗的重要性。因此，轉向個體化的植體周圍植入治療方案正成為臨床成功的關鍵。

人工智慧在治療植入炎的累積影響

人工智慧 (AI) 正開始影響植體植入炎的預防、診斷、工作流程最佳化和臨床決策支援。在植入領域，人們正在探索利用 AI 影像分析來輔助檢測X光相片和錐狀射束CT 影像中邊緣骨水平的變化，從而使臨床醫生能夠更早、更準確地識別植入骨吸收。機器學習模型還可以結合吸菸狀況、牙周炎病史、血糖控制、斑塊指數、出血指標、植入植入位置、義齒設計和維護依從性等臨床變量，輔助進行風險分層。當 AI 增強而非取代臨床判斷時，其累積影響最為顯著。 AI 驅動的病歷創建、X 光片圖像對比、隨訪預約的自動優先級排序以及患者溝通工具可以提高隨訪的一致性。這一點至關重要，因為植體周圍植入通常是在發生具有臨床意義的組織損傷後才被發現的。在研究領域，人工智慧可以加速證據整合、表現型分類和大規模臨床資料集的分析。然而，要使人工智慧成為植體植入疾病管理的常規標準，其應用必須解決數據品質、演算法檢驗、監管要求、互通性、減少偏差和透明的臨床管治等挑戰。

關於植體周圍植入的關鍵區域性見解

在亞太地區，都市區牙科植體的普及以及牙周病學和修復學專科診所的擴張，使得植入周圍炎日益受到臨床關注。儘管日本、韓國、中國、印度和澳洲的數位化植入工作流程正在不斷進步，但大都會圈和農村地區獲得標準化維護方案的機會卻存在顯著差異。北美地區的特點是植入已高度融入私人診所，X光監測已廣泛應用，並且越來越重視基於風險的複診計劃，尤其針對糖尿病患者、吸煙史患者或牙周炎病史患者。在拉丁美洲，人們對植入的功能性和美觀需求日益成長，巴西和墨西哥是重要的臨床教育和治療中心。然而，成本效益和追蹤的連續性仍然是影響植入炎治療效果的關鍵因素。在歐洲，成熟的牙周病研究網路、系統化的臨床指南以及人們對植入維護的高度重視，使得實證診斷和植入支持治療備受重視。在中東，尤其是在高所得的海灣市場，先進的牙科診所正在迅速發展，數位化牙科和專家主導的植入治療也日益普及。在非洲，植入的普及程度因地區而異，主要集中在都市區私立診所。人員培訓、費用障礙以及預防性維護的基礎設施建設是影響植入炎管理的關鍵挑戰。

植體植入炎的主要群體分析

在東南亞國協，隨著中產階級就醫管道的拓展、牙科旅遊的興起以及對私人診所的投資，對牙科植體的需求不斷成長。由於長期植入維護已成為衡量醫療品質的重要標準，植體周圍植入的預防也變得日益重要。在海灣合作理事會（GCC）國家，對高階牙科服務、數位影像和專家主導的診療模式的大力投入，為先進的診斷和治療提供了支持，但糖尿病等生活方式相關的風險因素也增加了對系統性植入監測的需求。歐盟為循證植入提供了健全的植入和臨床環境，並不斷加強品管系統、繼續教育和病人安全標準的統一。在金磚國家，植體周圍炎的趨勢各不相同。中國和印度的植入正在迅速提高，巴西則擁有完善的醫療保健和植入訓練體系。在俄羅斯，主要城市對功能植入植牙修復的需求仍然強勁；而在南非，私人植入治療的集中度正在不斷提高。儘管七國集團（G7）國家普遍擁有較高的牙周專科治療、數位化工作流程和維護方案的普及率，但它們也面臨著人口老化和慢性病負擔加重等挑戰，這些挑戰會使植入治療的效果變得複雜。北約成員國與北美和歐洲的先進牙科市場高度重合，這些地區臨床準備充分、學術研究成熟、監管環境完善，有利於更廣泛地採用植入炎的診斷和治療方案。

各國關於植體周圍植入的關鍵訊息

美國擁有高度發展的植入生態系統，植入炎的治療與牙周後續觀察以及患者對維護的依從性日益密切相關。在加拿大，儘管臨床意識和預防保健標準較高，但各省和保險覆蓋範圍可能存在差異。在墨西哥，國內植入需求和跨境牙科護理的結合使得維護的連續性成為至關重要的考慮因素。巴西擁有拉丁美洲最活躍的植入環境之一，這得益於專業的教育和豐富的臨床經驗，但患者對長期維護的依從性仍然至關重要。在英國，實證牙科和基於指引的牙周管理備受重視，植入疾病也擴大被納入專科轉診途徑。德國、法國、義大利和西班牙的植入市場均已成熟，其特點是擁有完善的專業教育、數位化牙科的普及以及對植體周圍支持植入護理日益成長的興趣。在俄羅斯，都市區對植入功能修復的需求很高，先進的治療集中在大型牙科中心。在中國，隨著都市區口腔醫療網路的普及和數位化技術的應用，植入的普及率迅速提高，這也使得植體植入炎的標準化診斷和維護變得尤為重要。在印度，雖然植入在私人牙科診所中越來越普遍，但缺乏完善的追蹤體系影響了疾病的預防。在日本，隨著人口老化和修復治療需求的增加，植入的健康狀況監測顯得尤為重要。在澳大利亞，預防牙科和專業的牙周治療緊密結合；而在韓國，先進的數位化牙科技術、精湛的臨床技術以及患者對植入修復治療的強烈需求共同推動了植牙領域的發展。

關於植體周圍植入的產業領導者實用建議

產業領導者應優先考慮「預防優先」的植入護理模式，該模式應從植入植入前開始，並貫穿整個植入生命週期。牙科專業人員和解決方案供應商應支援標準化的風險評估，評估內容應涵蓋牙周病史、吸菸史、糖尿病管理、斑塊控制、咬合、角化黏膜、植入位置和義齒清潔性。臨床團隊應記錄基準探診深度和義齒植入後的X光片，以提高未來診斷的準確性。教育計畫必須充分傳達以下訊息：如果及早處理，植體周圍植入炎是可逆的，而植入炎則需要更複雜的干預措施和長期維護。製造植入和臨床創新者應致力於設計便於口腔衛生管理、不易斑塊且在需要維護或修復時易於拆卸的植體和義齒。應利用數位化平台來提高追蹤率、X光片對比、患者提醒和治療結果追蹤。治療機構應採用實證的、針對特定病變的治療方案，而非依賴單一器械或輔助性治療。研究負責人應投入資源進行嚴謹的對比臨床研究，採用標準化的定義、患者報告結局指標和長期隨訪，以增強臨床對植體周圍植入治療的信心。

調查方法

本執行摘要是基於與植入炎、植體植入黏膜炎、牙科植體維護、牙周風險因素、診斷標準和治療方法相關的檢驗的臨床、監管、學術和公共衛生資訊來源的系統性回顧。調查方法著重於同儕審查的牙科和牙周病學文獻、共識研討會成果、臨床實踐指南、系統綜述以及經認證的公共衛生和專業教育資源中的證據。研究採用質性方法整合了各種見解，以識別疾病促進因素、不斷發展的診療路徑、區域實踐模式、技術應用趨勢和證據缺口。透過植入醫療保健基礎設施、植牙普及率、專科醫生資源、數位化牙科成熟度、與慢性疾病的關聯、成本效益考量以及診療連續性挑戰，得出區域、群體和國家層面的具體見解。本分析有意排除了市場規模估算、收入預測、佔有率計算和未來預測。觀點旨在為相關人員提供策略決策支持，以規範植體周圍植入的預防、診斷和治療，並提高植入的長期成功率。

結論

植體植入炎日益被認為是現代植入的一項重大臨床挑戰，需要採取涵蓋預防、診斷、治療創新和患者維護的協作方法。最有效的策略包括標準化評估、早期發現植入周圍黏膜炎、個人化風險管理以及針對特異性病變的治療，並輔以持續的追蹤。雖然數位化牙科和人工智慧可以提高監測效率和工作流程效率，但它們的價值取決於經過檢驗的工具、高品質的數據以及與負責任的臨床實踐的整合。區域間在醫療服務取得、培訓、報銷和維護系統方面的差異將繼續影響治療結果，因此制定在地化策略至關重要。對於產業領導者而言，未來的發展方向清晰明確：加強預防，在設計時充分考慮可維護性，支持臨床醫生教育，產生更高品質的證據，並賦予患者參與終身植入照護。透過將創新與循證的植入周圍健康管理相結合，牙科生態系統可以減少併發症，維持植入功能，並改善患者的長期預後。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 植體植入炎市場：依產品類型分類

  • 輔助器具
  • 雷射治療
  • 藥物治療
  • 手術治療
    • 嫁接材料的種類
      • 同種異體移植
      • 自體移植
      • 合成
      • 異質骨移植
    • 膜類型
      • 不吸收
      • 吸收性

第8章 植體周圍植入市場：依治療方式分類

  • 非手術治療
    • 局部抗菌治療
    • 機械清創
  • 手術治療
    • 再生療法
    • 切除術

第9章植入周圍炎市場：依植入材料分類

  • 鈦
  • 氧化鋯

第10章：植體周圍植入市場：依嚴重程度分類

  • 溫和的
  • 緩和
  • 嚴重

第11章 植體植入炎市場：依最終用戶分類

  • 門診手術中心
  • 牙醫診所
  • 醫院

第12章 植體植入炎市場：依分銷管道分類

  • 離線
  • 線上

第13章植入周圍炎市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 植體植入炎市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章植入周圍炎市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • BEGO GmbH & Co. KG
  • Botiss biomaterials GmbH
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Freiburger Medizintechnik GmbH
  • GalvoSurge Dental AG
  • GC Corporation
  • Geistlich Pharma AG
  • Henry Schein, Inc.
  • Institut Straumann AG
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Southern Implants（Pty）Ltd
  • W&H Dentalwerk Burmoos GmbH
  • ZimVie Inc.
Product Code: MRR-4103B31E019B

The Peri-implantitis Market is projected to grow by USD 1.90 billion at a CAGR of 6.50% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.30 billion
Forecast Year [2032] USD 1.90 billion
CAGR (%) 6.50%

Peri-implantitis Executive Summary

Peri-implantitis is a biofilm-associated, inflammatory condition affecting the tissues around dental implants, characterized by peri-implant mucosal inflammation and progressive loss of supporting bone. As dental implant therapy expands globally, peri-implant disease management has become a critical priority for dental clinicians, periodontists, oral surgeons, implant manufacturers, academic researchers, and healthcare payers. The condition is closely linked to plaque accumulation, prior periodontal disease, smoking, diabetes, inadequate maintenance, excess cement, prosthetic design limitations, and patient-specific immune responses. Current clinical attention is focused on early diagnosis, risk-based prevention, non-surgical debridement, regenerative and resective surgical approaches, implant surface decontamination, and long-term supportive peri-implant care. The peri-implantitis landscape is increasingly shaped by the need for evidence-based protocols, standardized case definitions, improved diagnostic accuracy, and therapies that preserve implant function while reducing recurrence. For stakeholders across oral healthcare, the opportunity lies in integrating prevention, digital monitoring, minimally invasive treatment, and patient adherence strategies into routine implant care pathways.

Transformative Shifts in the Peri-implantitis Landscape

The peri-implantitis landscape is undergoing transformative shifts driven by evolving clinical consensus, digital dentistry adoption, and a stronger emphasis on prevention. Historically, treatment approaches varied widely because disease definitions, severity grading, and outcome measures were inconsistent across clinical studies. The adoption of more standardized diagnostic frameworks has improved comparability and clinical decision-making, particularly around bleeding on probing, probing depth changes, suppuration, radiographic bone loss, and baseline implant records. At the same time, dental practices are moving from episodic intervention toward structured implant maintenance programs that include risk assessment, professional biofilm control, occlusal evaluation, and patient education. Treatment innovation is also reshaping care delivery. Air-abrasive decontamination, laser-assisted protocols, ultrasonic and titanium-compatible instrumentation, antiseptic adjuncts, local antimicrobials, regenerative biomaterials, and guided bone regeneration techniques are being evaluated to improve clinical outcomes. However, published evidence continues to show that no single modality is universally effective, reinforcing the importance of case selection, defect morphology, implant surface characteristics, and operator expertise. The shift toward personalized peri-implantitis management is therefore becoming central to clinical success.

Cumulative Impact of Artificial Intelligence on Peri-implantitis Care

Artificial intelligence is beginning to influence peri-implantitis prevention, diagnosis, workflow optimization, and clinical decision support. In implant dentistry, AI-enabled image analysis is being explored to support detection of marginal bone level changes on radiographs and cone-beam computed tomography images, helping clinicians identify early peri-implant bone loss more consistently. Machine learning models can also assist in risk stratification by combining clinical variables such as smoking status, history of periodontitis, glycemic control, plaque scores, bleeding indicators, implant location, prosthetic design, and maintenance compliance. The cumulative impact of AI is most meaningful when it strengthens-not replaces-clinical judgment. AI-supported charting, radiographic comparison, automated recall prioritization, and patient communication tools can improve follow-up consistency, which is essential because peri-implantitis is often detected after clinically meaningful tissue destruction has already occurred. In research settings, AI can accelerate evidence synthesis, phenotype classification, and analysis of large clinical datasets. Still, implementation must address data quality, algorithm validation, regulatory expectations, interoperability, bias mitigation, and transparent clinical governance before AI can become a routine standard in peri-implant disease management.

Key Regional Insights for Peri-implantitis

Asia-Pacific is experiencing rising clinical attention to peri-implantitis as dental implant adoption increases across urban centers and as specialty periodontal and prosthodontic services expand. Japan, South Korea, China, India, and Australia are advancing digital implant workflows, but access to standardized maintenance programs varies substantially between metropolitan and rural settings. North America is characterized by strong integration of implant dentistry into private dental practice, broad use of radiographic monitoring, and growing emphasis on risk-based recall programs, particularly for patients with diabetes, smoking exposure, or a history of periodontitis. Latin America shows increasing demand for implant rehabilitation and aesthetic dentistry, with Brazil and Mexico serving as important clinical education and treatment hubs; however, affordability and continuity of follow-up remain important determinants of peri-implantitis outcomes. Europe benefits from mature periodontal research networks, structured clinical guidelines, and high awareness of implant maintenance, with strong emphasis on evidence-based diagnosis and supportive peri-implant therapy. The Middle East is seeing rapid development of advanced dental clinics, especially in high-income Gulf markets, where digital dentistry and specialist-led implant care are increasingly common. Across Africa, implant dentistry is expanding unevenly, with access concentrated in private urban clinics; workforce training, cost barriers, and preventive maintenance infrastructure are central issues affecting peri-implantitis management.

Key Group Insights for Peri-implantitis

ASEAN countries are seeing growing demand for dental implants through expanding middle-class access, dental tourism, and private clinic investment, making peri-implantitis prevention increasingly relevant as long-term implant maintenance becomes a differentiator in care quality. In the GCC, high investment in premium dental services, digital imaging, and specialist-led care supports advanced diagnosis and treatment, while lifestyle-related risk factors such as diabetes heighten the need for structured peri-implant monitoring. The European Union provides a strong regulatory and clinical environment for evidence-based implant dentistry, with increasing alignment around quality systems, continuing professional education, and patient safety standards. BRICS countries show diverse peri-implantitis dynamics: China and India are scaling implant access rapidly, Brazil has a strong oral healthcare and implant training ecosystem, Russia maintains demand for implant rehabilitation across major cities, and South Africa reflects a more concentrated private-sector implant base. G7 countries generally demonstrate higher availability of specialist periodontal care, digital workflows, and maintenance protocols, but they also face aging populations and rising chronic disease burdens that complicate implant outcomes. NATO member countries overlap significantly with advanced dental markets in North America and Europe, where clinical readiness, academic research, and regulatory maturity support broader adoption of peri-implantitis diagnostic and treatment protocols.

Key Country Insights for Peri-implantitis

The United States has a highly developed implant dentistry ecosystem, with peri-implantitis management increasingly tied to periodontal risk assessment, radiographic surveillance, and maintenance compliance. Canada shows strong clinical awareness and preventive care standards, though access can vary by province and insurance coverage. Mexico combines domestic implant demand with cross-border dental care, making continuity of maintenance an important consideration. Brazil has one of the most active implant dentistry environments in Latin America, supported by specialist education and broad clinical experience, while patient adherence to long-term maintenance remains essential. The United Kingdom emphasizes evidence-based dental care and guideline-driven periodontal management, with peri-implant disease increasingly incorporated into specialist referral pathways. Germany, France, Italy, and Spain all demonstrate mature implant markets with strong professional education, digital dentistry adoption, and growing attention to supportive peri-implant therapy. Russia has significant urban demand for implant rehabilitation, with advanced care concentrated in major dental centers. China is rapidly expanding implant access through urban dental networks and digital technology adoption, creating a growing need for standardized peri-implantitis diagnosis and maintenance. India is experiencing increasing implant uptake in private practices, but variability in follow-up systems influences disease prevention. Japan faces an aging population with high restorative needs, making peri-implant health monitoring particularly important. Australia shows strong alignment with preventive dentistry and specialist periodontal care, while South Korea combines advanced digital dentistry, high clinical sophistication, and strong patient demand for implant-supported rehabilitation.

Actionable Recommendations for Peri-implantitis Industry Leaders

Industry leaders should prioritize prevention-first peri-implant care models that begin before implant placement and continue throughout the implant lifecycle. Dental professionals and solution providers should support standardized risk assessment covering periodontal history, smoking, diabetes control, plaque control, occlusion, keratinized mucosa, implant position, and prosthetic cleanability. Clinical teams should document baseline probing depths and radiographs after prosthesis delivery to improve future diagnosis. Education programs must reinforce that peri-implant mucositis is reversible when addressed early, while peri-implantitis requires more complex intervention and long-term maintenance. Manufacturers and clinical innovators should focus on implant and prosthetic designs that improve hygiene access, reduce plaque-retentive features, and support retrievability when maintenance or repair is needed. Digital platforms should be used to improve recall adherence, radiographic comparison, patient reminders, and outcome tracking. Treatment providers should adopt evidence-based, defect-specific protocols rather than relying on a single device or adjunctive therapy. Research leaders should invest in robust comparative clinical studies with standardized definitions, patient-reported outcomes, and long-term follow-up to strengthen clinical confidence in peri-implantitis interventions.

Research Methodology

This executive summary is based on a structured review of verified clinical, regulatory, academic, and public health sources related to peri-implantitis, peri-implant mucositis, dental implant maintenance, periodontal risk factors, diagnostic criteria, and treatment approaches. The methodology emphasizes evidence from peer-reviewed dental and periodontal literature, consensus workshop outputs, clinical practice guidelines, systematic reviews, and recognized public health and professional education resources. Insights were synthesized qualitatively to identify disease drivers, care pathway shifts, regional practice patterns, technology adoption trends, and evidence gaps. Regional, group, and country insights were developed by assessing oral healthcare infrastructure, implant dentistry adoption, specialist availability, digital dentistry maturity, chronic disease relevance, affordability considerations, and continuity of care challenges. The analysis intentionally excludes market sizing, revenue estimation, share calculation, and forecasting. The resulting perspective is designed to support strategic decision-making for stakeholders seeking to improve peri-implantitis prevention, diagnosis, treatment standardization, and long-term implant success.

Conclusion

Peri-implantitis is increasingly recognized as a major clinical challenge in modern implant dentistry, requiring coordinated action across prevention, diagnostics, treatment innovation, and patient maintenance. The most effective strategies are likely to combine standardized assessment, early identification of peri-implant mucositis, individualized risk management, and defect-specific therapy supported by consistent follow-up. Digital dentistry and artificial intelligence can improve monitoring and workflow efficiency, but their value depends on validated tools, high-quality data, and responsible clinical integration. Regional differences in access, training, reimbursement, and maintenance infrastructure will continue to influence outcomes, making localized strategies essential. For industry leaders, the path forward is clear: strengthen prevention, design for maintainability, support clinician education, generate higher-quality evidence, and empower patients to participate in lifelong implant care. By aligning innovation with evidence-based peri-implant health management, the dental ecosystem can reduce complications, preserve implant function, and improve long-term patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Peri-implantitis Market, by Product Type

  • 7.1. Introduction
  • 7.2. Adjunctive Devices
  • 7.3. Laser Treatment
  • 7.4. Pharmacological Treatment
  • 7.5. Surgical Treatment
    • 7.5.1. Graft Type
      • 7.5.1.1. Allograft
      • 7.5.1.2. Autograft
      • 7.5.1.3. Synthetic
      • 7.5.1.4. Xenograft
    • 7.5.2. Membrane Type
      • 7.5.2.1. Non-Resorbable
      • 7.5.2.2. Resorbable

8. Peri-implantitis Market, by Treatment Modality

  • 8.1. Introduction
  • 8.2. Non Surgical
    • 8.2.1. Local Antibiotic Therapy
    • 8.2.2. Mechanical Debridement
  • 8.3. Surgical
    • 8.3.1. Regenerative Procedures
    • 8.3.2. Resective Procedures

9. Peri-implantitis Market, by Implant Material

  • 9.1. Introduction
  • 9.2. Titanium
  • 9.3. Zirconia

10. Peri-implantitis Market, by Severity

  • 10.1. Introduction
  • 10.2. Mild
  • 10.3. Moderate
  • 10.4. Severe

11. Peri-implantitis Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgery Centers
  • 11.3. Dental Clinics
  • 11.4. Hospitals

12. Peri-implantitis Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
  • 12.3. Online

13. Peri-implantitis Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Peri-implantitis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peri-implantitis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. BEGO GmbH & Co. KG
  • 17.2. Botiss biomaterials GmbH
  • 17.3. Dentium Co., Ltd.
  • 17.4. Dentsply Sirona Inc.
  • 17.5. Freiburger Medizintechnik GmbH
  • 17.6. GalvoSurge Dental AG
  • 17.7. GC Corporation
  • 17.8. Geistlich Pharma AG
  • 17.9. Henry Schein, Inc.
  • 17.10. Institut Straumann AG
  • 17.11. Megagen Implant Co., Ltd.
  • 17.12. Nobel Biocare Services AG
  • 17.13. Southern Implants (Pty) Ltd
  • 17.14. W&H Dentalwerk Burmoos GmbH
  • 17.15. ZimVie Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERI-IMPLANTITIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PERI-IMPLANTITIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LASER TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LASER TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LASER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GRAFT TYPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GRAFT TYPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GRAFT TYPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALLOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ALLOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALLOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE TYPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE TYPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE TYPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON SURGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON SURGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON SURGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ZIRCONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ZIRCONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ZIRCONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MILD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MILD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MILD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MODERATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MODERATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MODERATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SEVERE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SEVERE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SEVERE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 186. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. G7 PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 218. G7 PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. NATO PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. NATO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 230. NATO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 234. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. BRAZIL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. FRANCE PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 324. RUSSIA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. ITALY PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. ITALY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. ITALY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 348. SPAIN PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 349. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 351. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 354. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 355. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 356. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 357. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 358. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 360. CHINA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. CHINA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 362. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 363. CHINA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. CHINA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 366. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 367. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 372. INDIA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 373. INDIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 374. INDIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLIO